[Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
Two patients who were admitted to hospital with severe obsessive compulsive disorders (OCD) improved dramatically after treatment with the MAO-Inhibitor tranylcypromine. The possibility of treating obsessive-compulsive disorders with MAO-Inhibitors and serotonergic drugs is discussed.
Erfurth
A
A
Psychiatrische Klinik, Universität München.
Schmauss
M
M
D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D014191:Tranylcypromine / Q000627:therapeutic use; D014268:Trifluoperazine / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D014268:Trifluoperazine; D014191:Tranylcypromine